1. Home
  2. ELVR vs TBPH Comparison

ELVR vs TBPH Comparison

Compare ELVR & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELVR

Sayona Mining Limited American Depository Shares

N/A

Current Price

$65.45

Market Cap

890.2M

Sector

Industrials

ML Signal

N/A

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$20.27

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELVR
TBPH
Founded
2000
2013
Country
Australia
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
890.2M
993.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ELVR
TBPH
Price
$65.45
$20.27
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$27.80
AVG Volume (30 Days)
82.4K
421.4K
Earning Date
03-12-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.58
Revenue
$146,440,045.00
$80,327,000.00
Revenue This Year
$22.93
$70.78
Revenue Next Year
$7.27
N/A
P/E Ratio
N/A
$35.19
Revenue Growth
11.20
27.12
52 Week Low
$15.55
$7.90
52 Week High
$69.99
$21.00

Technical Indicators

Market Signals
Indicator
ELVR
TBPH
Relative Strength Index (RSI) N/A 64.21
Support Level N/A $19.53
Resistance Level N/A $21.00
Average True Range (ATR) 0.00 0.81
MACD 0.00 0.11
Stochastic Oscillator 0.00 79.77

Price Performance

Historical Comparison
ELVR
TBPH

About ELVR Sayona Mining Limited American Depository Shares

Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is the identification, acquisition, and evaluation of mineral exploration assets, focusing on lithium. The projects of the company include the Moblan Lithium Project, the Carolina Lithium Project, the Ewoyaa Lithium Project, North American Lithium, and other projects. The company also holds an interest in a tenement portfolio in the Pilbara region, prospective for gold and lithium.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: